|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 57.55M 4.45M 4.16M 3.81M 7.15M 497M 7.25M 49.21M 19.19M 250M 19.51M 19.09M 826M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 116M 8.95M 8.37M 7.66M 14.38M 999M 14.57M 98.92M 38.58M 502M 39.22M 38.37M 1.66B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 915K | ||
| +0.88% | +6.38% | +76.40% | +126.87% | 1,119B | ||
| +1.07% | +3.80% | +50.73% | +64.25% | 651B | ||
| +1.20% | +6.21% | +25.81% | +80.15% | 468B | ||
| +1.02% | +5.77% | +43.63% | +43.06% | 374B | ||
| +0.85% | +4.07% | +24.97% | +41.00% | 302B | ||
| +1.26% | +6.81% | +2.27% | +13.65% | 259B | ||
| +1.88% | +5.81% | +49.57% | +70.71% | 238B | ||
| +1.59% | +2.09% | -17.33% | -53.85% | 208B | ||
| +1.87% | +5.61% | +27.32% | +89.67% | 181B | ||
| Average | +1.29% | +5.17% | +31.49% | +52.83% | 379.99B | |
| Weighted average by Cap. | +1.14% | +5.40% | +44.26% | +72.42% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 98.49M 7.62M 7.13M 6.52M 12.24M 851M 12.41M 84.21M 32.84M 427M 33.39M 32.66M 1.41B | 9.91M 110M 8.49M 7.94M 7.27M 13.64M 948M 13.82M 93.84M 36.59M 476M 37.21M 36.4M 1.58B |
| Net income | 665K 7.37M 570K 533K 488K 916K 63.63M 928K 6.3M 2.46M 31.96M 2.5M 2.44M 106M | 762K 8.43M 652K 610K 559K 1.05M 72.86M 1.06M 7.21M 2.81M 36.6M 2.86M 2.8M 121M |
| Net Debt | 4.15M 45.93M 3.55M 3.32M 3.04M 5.71M 397M 5.79M 39.27M 15.31M 199M 15.57M 15.23M 659M | 5.25M 58.14M 4.5M 4.21M 3.85M 7.23M 502M 7.32M 49.71M 19.39M 252M 19.71M 19.28M 835M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















